ScreenerHero

EXTX EXACT Therapeutics AS

OSL · NO · Healthcare · Biotechnology · exact-tx.com
0.5800NOK-14.07%Mkt Cap: 6.05M $P/E: —

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a novel ultrasound-mediated technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT) in Norway. The ACT is an ap…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap6.05M USD
Enterprise Value-592.35K USD
Revenue (TTM)7.29K USD
Gross Profit7.29K USD
Net Income (TTM)-8.13M USD
Revenue/Share0.0010 NOK
Last Price0.5800 NOK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11
CountryNO
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA0.09
EV/Revenue-81.24
P/S965.29
P/B0.65
EPS (TTM)-0.93
EPS (Forward)—
52W Range
0.58000% of range2.780
52W High2.780 NOK
52W Low0.5800 NOK
Profitability
Gross Margin100.00%
Oper. Margin-199799.21%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-283.21%
ROA-129.04%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.26M USD
CapEx (TTM)497.32K USD
FCF Margin-73203.61%
FCF Yield-88.26%
Net Debt-4.58M USD
Net Debt/EBITDA0.66
Balance Sheet
Debt/Equity0.01
Current Ratio4.16
Quick Ratio3.09
Book Value/Sh1.04 NOK
Cash/Share0.78 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 NOK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split250:1
Split DateJul 27, 2020
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.111.54M
Float62.69M
Insiders33.49%
Institutions12.93%
Technical
SMA 500.7356 (-21.2%)
SMA 2001.283 (-54.8%)
Beta0.09
S&P 52W Chg14.58%
Avg Vol (30d)65.71K
Avg Vol (10d)104.11K
Technical Indicators
RSI (14)39.9
MACD-0.0178
MACD Signal-0.0010
MACD Hist.-0.0169
BB Upper0.8828 NOK
BB Middle0.7368 NOK
BB Lower0.5907 NOK
BB Width39.65%
ATR (14)0.1042 NOK
Vol Ratio (20d)1.56x